Celecoxib: all 393 studies that test it
Page 3 of 4. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.
- Celecoxib for the Treatment of Non-muscle Invasive Bladder CancerCompletedNCT02343614Phase 2
- Low Dose Metronomic Poly-chemotherapy for Metastatic CRCCompletedNCT02280694Phase 2
- Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion InjuryStatus unknownNCT02255006Not applicable
- Efficacy and Safety of Postoperative Intravenous Parecoxib Sodium Followed by Oral Celecoxib in Osteoarthritis PatientsCompletedNCT02198924Phase 4
- Effect of a Multimodal Pain Regimen on Pain Control, Patient Satisfaction and Narcotic Use in Orthopaedic Trauma PatientsWithdrawnNCT02160301Phase 4
- Intravitreal Celecoxib for Chronic UveitisTerminatedNCT02131012Phase 1
- Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic GliomasCompletedNCT02115074Phase 1
- Decreasing Narcotics in Advanced Pelvic SurgeryCompletedNCT02110719Phase 4
- Treatment of Severe Influenza A InfectionCompletedNCT02108366Phase 3
- Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy VolunteersCompletedNCT02099136Phase 2
- Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy VolunteersCompletedNCT02090933Phase 2
- Tramadol Versus Celecoxib for Reducing Pain in Outpatient HysteroscopyCompletedNCT02071303Phase 2
- N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/TopotecanCompletedNCT02030964Phase 1
- Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing SpondylitisCompletedNCT01934933Phase 4
- Window of Opportunity Study Targeting the Inflammatory MilieuCompletedNCT01881048Early Phase 1
- NSAID Treatment in Knee OsteoarthritisCompletedNCT01860833Phase 4
- Urinary NGF as A Biomarker for Acute Bacterial CystitisCompletedNCT01800799Not applicable
- Low Dose Aspirin Inhibition of COX-2 Derived PGE2 in Male SmokersCompletedNCT01796951Early Phase 1
- CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and AcetaminophenCompletedNCT01762891Not applicable
- ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic TumorsCompletedNCT01756989Phase 2
- Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast CancerCompletedNCT01695226Phase 2
- Maintenance Metronomic Chemotherapy for Metastatic Colorectal CarcinomaTerminatedNCT01668680Phase 2
- Celecoxib for Primary Prophylaxis of Combat-Related Heterotopic OssificationStatus unknownNCT01631669Not applicable
- Statins and Selective Cyclooxygenase-2 Receptor Inhibitors in Blunt Chest TraumaStatus unknownNCT01623921Not applicable
- The Pharmacokinetic Interaction Between Celecoxib and RebamipideCompletedNCT01549743Phase 1
- Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01503385Phase 2
- Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin InhibitorsCompletedNCT01425476Phase 1/2
- Pregabalin, Celecoxib, Total Knee Arthroplasty and Intrathecal MorphineCompletedNCT01344213Phase 4
- Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor RemovalTerminatedNCT01341496Phase 1
- Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or MediastinumTerminatedNCT01313429Phase 1
- A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours.CompletedNCT01285817Phase 2
- Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural MesotheliomasTerminatedNCT01258868Phase 1
- Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment StrategyTerminatedNCT01175772Phase 2
- Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural MesotheliomasTerminatedNCT01143545Phase 1
- Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer PatientsCompletedNCT01124435Phase 2
- A Study to Verify the Efficacy of YM177 (Celecoxib) in Postoperative Pain PatientsCompletedNCT01118572Phase 3
- Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas CancerStatus unknownNCT01111591Phase 4
- Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast CancerTerminatedNCT01067989Phase 2
- Study of Epicutaneously Applied Ketoprofen Transfersome® Gel With or Without Combination With Oral Celecoxib for the Treatment of Muscle Pain Induced by Eccentric ExerciseCompletedNCT01020279Phase 1
- Preemptive Analgesia in Cruciate ReconstructionCompletedNCT01017380Phase 3
- Celecoxib as a Chemopreventive Agent in Current and Former SmokersCompletedNCT00981201Phase 3
- A Study of High-Risk Oral Cavity CancerTerminatedNCT00934739Phase 2/3
- Trial of Celecoxib With Preoperative Chemo- Radiation for Locally Advanced Rectal CancerCompletedNCT00931203Phase 2
- The Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel in Normal VolunteersCompletedNCT00882388Phase 4
- Celecoxib for Pediatric AdenotonsillectomyCompletedNCT00849966Phase 2
- Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal UlcersCompletedNCT00778193Phase 4
- Phase I Study to Evaluate Bioavailability of Overencapsulated CelecoxibCompletedNCT00729495Phase 1
- A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode SchizophreniaCompletedNCT00686140Not applicable
- Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous PolyposisCompletedNCT00685568Phase 1
- Effect of Celecoxib on Transitional Pain After Outpatient SurgeryWithdrawnNCT00664690Phase 4
- Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung CancerCompletedNCT00653250Not applicable
- A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRACompletedNCT00652925Phase 3
- Safety and Efficacy of Celecoxib Versus Diclofenac in the Treatment of Ankylosing SpondylitisCompletedNCT00648141Phase 3
- Safety and Efficacy of Celecoxib Versus Naproxen in the 6-month Treatment of Knee OsteoarthritisCompletedNCT00643799Phase 4
- Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus OmeprazoleCompletedNCT00640809Phase 4
- Efficacy and Safety of Celecoxib Versus Placebo in the Treatment of Patients With Osteoarthritis of the Knee Who Were Unresponsive to Naproxen and IbuprofenCompletedNCT00640627Phase 4
- Safety And Efficacy Of Celecoxib Versus Sodium Diclofenac In The Treatment Of Acute Low Back PainCompletedNCT00640432Phase 4
- Efficacy and Safety of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With SchizophreniaCompletedNCT00639483Phase 2
- Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and IbuprofenCompletedNCT00638807Phase 4
- Effect of Celecoxib Versus Placebo Before and After Knee Surgery on Overall Use of Analgesics After SurgeryCompletedNCT00633438Phase 4
- Effect of Celecoxib Versus Placebo Before and After Knee Surgery on the Overall Use of Analgesics After SurgeryCompletedNCT00633386Phase 4
- Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (Europe)CompletedNCT00630929Phase 4
- Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (United States)CompletedNCT00620867Phase 4
- Celecoxib in Treating Patients With Early-Stage Rectal CancerTerminatedNCT00608595Not applicable
- COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck CarcinomaStatus unknownNCT00603759Phase 3
- Perioperative Pain Control With Celecoxib (Celebrex) in Total Knee ArthroplastyCompletedNCT00598234Phase 4
- Efficacy of Celecoxib 200mg in Relieving Pain and Walking Dysfunction in Osteoarthritis of the KneeStatus unknownNCT00597415Phase 2
- Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell CarcinomaCompletedNCT00596219Not applicable
- Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal CancerStatus unknownNCT00589186Phase 2
- The Effects of Celecoxib on Bone IngrowthTerminatedNCT00585156Early Phase 1
- Celecoxib, Ibuprofen and the Antiplatelet Effect of AspirinCompletedNCT00565500Phase 4
- Cyclophosphamide and Celecoxib in Treating Patients With Advanced CancerCompletedNCT00551889Phase 1
- Etoposide and Celecoxib in Patients With Advanced CancerCompletedNCT00551005Phase 1
- Arthroplasty Inflammation Prophylaxis With CelecoxibStatus unknownNCT00533247Not applicable
- Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast CancerCompletedNCT00525096Phase 3
- Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal CancerCompletedNCT00520091Phase 2
- Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis TrialStatus unknownNCT00500279Phase 4
- Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic CancerStatus unknownNCT00486460Phase 3
- Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer PatientsCompletedNCT00473980Phase 4
- Effect of Celecoxib on Markers of Vascular InflammationCompletedNCT00471341Phase 4
- Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by SurgeryCompletedNCT00450736Phase 1
- The Standard Care Versus Celecoxib Outcome TrialCompletedNCT00447759Phase 4
- Clinical Trial of a COX-2 Inhibitor for the Treatment of Women With PreeclampsiaWithdrawnNCT00442676Phase 2
- Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2CompletedNCT00400374Phase 1
- Preventing Recurrent Ulcer Bleeding in Arthritis Patients Using Esomeprazole Plus CelecoxibCompletedNCT00365313Phase 3
- Celebrex Total Knee Arthroplasty StudyTerminatedNCT00359151Phase 4
- Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By SurgeryStatus unknownNCT00357617Phase 1/2
- Combination Therapy Selection Trial in Amyotrophic Lateral SclerosisCompletedNCT00355576Phase 2
- A Study Comparing the Effectiveness and Safety of Extended Release Tramadol HCl at 100 mg, 200 mg and 300 mg Doses to Placebo for the Treatment of Moderate to Severe Pain Due to Osteoarthritis (OA)CompletedNCT00348452Phase 3
- CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00346801Phase 1
- Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By SurgeryCompletedNCT00336960Phase 2
- A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/MastectomyCompletedNCT00328432Phase 1
- Celecoxib (Celebrex) in the Management of Acute Renal ColicWithdrawnNCT00304317Phase 4
- Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving ChemotherapyStatus unknownNCT00300729Phase 3
- Study of Celecoxib Bioavailability in Healthy SubjectsCompletedNCT00296127Phase 1
- Celecoxib and Erlotinib in Treating Patients With Liver CancerWithdrawnNCT00293436Phase 1/2
- Effects of Celecoxib After Percutaneous Coronary InterventionCompletedNCT00292721Phase 4
- Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.CompletedNCT00290901Phase 4
- Bortezomib and Celecoxib in Treating Patients With Advanced Solid TumorsCompletedNCT00290680Phase 1
- Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung CancerStatus unknownNCT00274898Phase 2